Professor | Jianghong Yan | Asia Growth Partners

Upload Avatar (500 x 500)

Name

Jianghong Yan

Contact Information

yanjianghong@cqmu.edu.cn

Language ability

Chinese, English

Province

Chongqing

University/Lab Affiliation and Title	Chongqing Medical University
Faculty	Basic Medical Sciences
Awards	Chongqing Medical University Outstanding Young Scholar Fund

University/Lab Affiliation and Title

Chongqing Medical University

Faculty

Basic Medical Sciences

Awards

Areas of Focus	Molecular Oncology Cardiovascular Pharmacology
Publications	Tubeimoside I Ameliorates Myocardial Ischemia-Reperfusion Injury through SIRT3-Dependent Regulation of Oxidative Stress and Apoptosis, Dingyi Lv, Minghao Luo, Zhe Cheng, Ruiyu Wang, Xiyang Yang, Yongzheng Guo, Longxiang Huang, Xiang Li, Bi Huang, Jian Shen, Suxin Luo, Jianghong Yan, 2021 Tubeimoside I improves endothelial function in sepsis via activation of SIRT3, Xiyang Yang, Xingbing Li, Minghao Luo, Chang Li, Longxiang Huang, Xiang Li, Bi Huang, Jiang Shen, Suxin Luo, Jianghong Yan, 2021 Tubeimoside I promotes angiogenesis via activation of eNOS-VEGF signaling pathway, Xiyang Yang, Xingbing Li, Minghao Luo, Yongzheng Guo, Chang Li, Dingyi Lv, Zhe Cheng, Longxiang Huang, Fei-Fei Shang, Bi Huang, Jian Shen, Suxin Luo, Jianghong Yan, 2021 Tubeimoside I improves survival of mice in sepsis by inhibiting inducible nitric oxide synthase expression, Minghao Luo, Suxin Luo, Zhe Cheng, Xiyang Yang, Dingyi Lv, Xingbing Li, Yongzheng Guo, Chang Li, Jianghong Yan, 2020 Tubeimoside I sensitizes colorectal cancer cells to chemotherapy by inducing ROS-mediated impaired autophagolysosomes accumulation, Jianghong Yan, Xiaoyun Dou, Jing Zhou, Yuanfeng Xiong, Ling Mo, Longhao Li, Yunlong Lei, 2019

Areas of Focus

Molecular Oncology
Cardiovascular Pharmacology

Publications

Tubeimoside I Ameliorates Myocardial Ischemia-Reperfusion Injury through SIRT3-Dependent Regulation of Oxidative Stress and Apoptosis, Dingyi Lv, Minghao Luo, Zhe Cheng, Ruiyu Wang, Xiyang Yang, Yongzheng Guo, Longxiang Huang, Xiang Li, Bi Huang, Jian Shen, Suxin Luo, Jianghong Yan, 2021
Tubeimoside I improves endothelial function in sepsis via activation of SIRT3, Xiyang Yang, Xingbing Li, Minghao Luo, Chang Li, Longxiang Huang, Xiang Li, Bi Huang, Jiang Shen, Suxin Luo, Jianghong Yan, 2021
Tubeimoside I promotes angiogenesis via activation of eNOS-VEGF signaling pathway, Xiyang Yang, Xingbing Li, Minghao Luo, Yongzheng Guo, Chang Li, Dingyi Lv, Zhe Cheng, Longxiang Huang, Fei-Fei Shang, Bi Huang, Jian Shen, Suxin Luo, Jianghong Yan, 2021
Tubeimoside I improves survival of mice in sepsis by inhibiting inducible nitric oxide synthase expression, Minghao Luo, Suxin Luo, Zhe Cheng, Xiyang Yang, Dingyi Lv, Xingbing Li, Yongzheng Guo, Chang Li, Jianghong Yan, 2020
Tubeimoside I sensitizes colorectal cancer cells to chemotherapy by inducing ROS-mediated impaired autophagolysosomes accumulation, Jianghong Yan, Xiaoyun Dou, Jing Zhou, Yuanfeng Xiong, Ling Mo, Longhao Li, Yunlong Lei, 2019

Cancer Tumor Molecular Biology Oncology Pharmacology Cardiovascular Heart Disease Therapy Research

Er Dan Dong - Peking University

Kong Wei - Peking University

Xunde Xian - Peking University

View All

Personal Information